Table: OncoTherapy Science -2021/22 parent results

OncoTherapy Science

06/05/2022 09:00

May 6 (Reuters)- 
          OncoTherapy Science Inc 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to     NEXT     
              Mar 31, 2022    Mar 31, 2021   Mar 31, 2023     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           7 mln          111 mln                               
               (-93.4 pct)     (-2.7 pct)                              
  Operating     loss 2.02       loss 1.37                              
  Recurring     loss 2.01       loss 1.34                              
  Net           loss 2.43       loss 1.55                              
  EPS        loss 12.94 yen   loss 8.77 yen                            
  Ann Div          NIL             NIL            NIL                  
  -Q4 Div          NIL             NIL            NIL                  
  
  NOTE - OncoTherapy Science Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4564.T